Amy E Gates

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi Biology and management of AIDS-associated non-Hodgkin's lymphoma
    Amy E Gates
    Positive Health Program, San Francisco General Hospital, University of California at San Francisco, 995 Potrero Avenue, Building 80, Ward 84, San Francisco, CA 94110, USA
    Hematol Oncol Clin North Am 17:821-41. 2003
  2. ncbi AIDS malignancies in the era of highly active antiretroviral therapy
    Amy E Gates
    University of California, San Francisco, San Francisco General Hospital, 94110, USA
    Oncology (Williston Park) 16:657-65; discussion 665, 668-70. 2002
  3. ncbi AIDS malignancies in the era of highly active antiretroviral therapy
    Amy E Gates
    University of California, San Francisco, USA
    Oncology (Williston Park) 16:441-51, 456, 459. 2002

Collaborators

Detail Information

Publications3

  1. ncbi Biology and management of AIDS-associated non-Hodgkin's lymphoma
    Amy E Gates
    Positive Health Program, San Francisco General Hospital, University of California at San Francisco, 995 Potrero Avenue, Building 80, Ward 84, San Francisco, CA 94110, USA
    Hematol Oncol Clin North Am 17:821-41. 2003
    ..Whether outcomes are improved with combination chemotherapy and HAART remains unclear. Efforts aimed at developing pathogenic-based therapies will continue as the mechanisms of HIV lymphomagenesis are elucidated...
  2. ncbi AIDS malignancies in the era of highly active antiretroviral therapy
    Amy E Gates
    University of California, San Francisco, San Francisco General Hospital, 94110, USA
    Oncology (Williston Park) 16:657-65; discussion 665, 668-70. 2002
    ..This two-part article, which began in the April 2002 issue, analyzes the impact of HAART on the incidence, clinical course, and outcomes of each of the AIDS-related malignancies...
  3. ncbi AIDS malignancies in the era of highly active antiretroviral therapy
    Amy E Gates
    University of California, San Francisco, USA
    Oncology (Williston Park) 16:441-51, 456, 459. 2002
    ..This two-part article, which will conclude in the May 2002 issue, analyzes the impact of HAARTon the incidence, clinical course, and outcomes of each of the AIDS-related malignancies...